pSivida Corp

PATIENT ADVOCACY / PANCREATIC CANCER

Pancreatic cancer is the fourth most frequent cause of cancer death and one of the world’s most aggressive cancers with an average five-year survival rate of 4%. Over 80% of patients present with inoperable locally advanced or metastatic disease. The median survival for these patients following diagnosis is typically less than 178 days with standard chemotherapy.


Each year more than 30,000 people in the United States are diagnosed with pancreatic cancer and more than twice that in Europe. The incidence of pancreatic cancer increases with age; most people are between the ages of 60 to 80 when they receive the diagnosis. In the U.S., pancreatic cancer is the ninth or tenth most commonly diagnosed cancer (depending on gender), but the fourth leading cause of cancer death in men and women. The median survival period is arguably the worst of any of the cancers.

There is a significant amount of information available regarding Pancreatic Cancer, for more information click on any of the following links:

http://www.cancer.gov/cancertopics/types/pancreatic

http://www.pancreatica.org

pSivida